Article By:
TipRanks
Wednesday, September 12, 2018 3:22 PM EDT
September is typically an ugly month for stocks. Biotech stocks march to a different tune. They can spike massively on positive news — be it key trial results or regulatory approvals.
In this article: SRNE, GLMD, TOCA, SBPH, OBSV